These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 15561821

  • 1. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
    Poirel L, Mammeri H, Nordmann P.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4528-31. PubMed ID: 15561821
    [Abstract] [Full Text] [Related]

  • 2. E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
    Perilli M, Celenza G, De Santis F, Pellegrini C, Forcella C, Rossolini GM, Stefani S, Amicosante G.
    Antimicrob Agents Chemother; 2008 Mar; 52(3):915-9. PubMed ID: 18160520
    [Abstract] [Full Text] [Related]

  • 3. BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa.
    Poirel L, Brinas L, Verlinde A, Ide L, Nordmann P.
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3743-8. PubMed ID: 16127048
    [Abstract] [Full Text] [Related]

  • 4. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L, Alba J, Chang FY, Ishiguro M, Yamaguchi K, Siu LK, Ishii Y.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [Abstract] [Full Text] [Related]

  • 5. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y, Wachino J, Ishiguro M, Kurokawa H, Yamane K, Shibata N, Shibayama K, Yokoyama K, Kato H, Yagi T, Arakawa Y.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH, Hu ZQ, Chen G, Ito R, Shimamura T.
    Chemotherapy; 2008 Jul; 54(1):31-7. PubMed ID: 18063864
    [Abstract] [Full Text] [Related]

  • 12. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
    Wachino J, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T, Ito H, Arakawa Y.
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH, Bae IK, Kwon SB, Lee JH, Song JS, Jung HI, Sung KH, Jang SJ, Lee SH.
    J Appl Microbiol; 2005 Jun; 98(4):921-7. PubMed ID: 15752339
    [Abstract] [Full Text] [Related]

  • 15. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 Jun; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 16. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
    Beceiro A, Maharjan S, Gaulton T, Doumith M, Soares NC, Dhanji H, Warner M, Doyle M, Hickey M, Downie G, Bou G, Livermore DM, Woodford N.
    J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679
    [Abstract] [Full Text] [Related]

  • 17. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
    Mammeri H, Nazic H, Naas T, Poirel L, Léotard S, Nordmann P.
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4050-3. PubMed ID: 15388478
    [Abstract] [Full Text] [Related]

  • 18. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase.
    Fernández-Cuenca F, Rodríguez-Martínez JM, Martínez-Martínez L, Pascual A.
    Int J Antimicrob Agents; 2006 Jun; 27(6):549-52. PubMed ID: 16697150
    [Abstract] [Full Text] [Related]

  • 19. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H, Poirel L, Nordmann P.
    J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.